285 related articles for article (PubMed ID: 25266928)
1. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
[TBL] [Abstract][Full Text] [Related]
2. Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa.
Bestawros M; Chidumayo T; Blevins M; Canipe A; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
J AIDS Clin Res; 2015 Mar; 6(3):. PubMed ID: 26038711
[TBL] [Abstract][Full Text] [Related]
3. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
4. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
5. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
6. Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.
Koethe JR; Blevins M; Nyirenda C; Kabagambe EK; Shepherd BE; Wester CW; Zulu I; Chiasera JM; Mulenga LB; Mwango A; Heimburger DC
J Int AIDS Soc; 2011 Apr; 14():19. PubMed ID: 21477359
[TBL] [Abstract][Full Text] [Related]
7. Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa.
Pillay K; Lewis L; Rambaran S; Yende-Zuma N; Archary D; Gengiah S; Govender D; Hassan-Moosa R; Samsunder N; Abdool Karim SS; McKinnon LR; Padayatchi N; Naidoo K; Sivro A
Front Immunol; 2021; 12():631094. PubMed ID: 33841412
[TBL] [Abstract][Full Text] [Related]
8. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.
Villar-García J; Hernández JJ; Güerri-Fernández R; González A; Lerma E; Guelar A; Saenz D; Sorlí L; Montero M; Horcajada JP; Knobel Freud H
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):256-63. PubMed ID: 25469528
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of systemic inflammation and recovery of lean body mass among malnourished HIV-infected adults starting antiretroviral therapy in Tanzania and Zambia.
PrayGod G; Blevins M; Woodd S; Rehman AM; Jeremiah K; Friis H; Kelly P; Changalucha J; Heimburger DC; Filteau S; Koethe JR
Eur J Clin Nutr; 2016 Apr; 70(4):499-504. PubMed ID: 26785764
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults.
Stehle JR; Leng X; Kitzman DW; Nicklas BJ; Kritchevsky SB; High KP
J Gerontol A Biol Sci Med Sci; 2012 Nov; 67(11):1212-8. PubMed ID: 22960476
[TBL] [Abstract][Full Text] [Related]
11. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
12. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
13. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
14. Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.
Muenchhoff M; Healy M; Singh R; Roider J; Groll A; Kindra C; Sibaya T; Moonsamy A; McGregor C; Phan MQ; Palma A; Kloverpris H; Leslie A; Bobat R; LaRussa P; Ndung'u T; Goulder P; Sobieszczyk ME; Archary M
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):46-55. PubMed ID: 28670966
[TBL] [Abstract][Full Text] [Related]
15. Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa.
Koethe JR; Blevins M; Bosire C; Nyirenda C; Kabagambe EK; Mwango A; Kasongo W; Zulu I; Shepherd BE; Heimburger DC
Public Health Nutr; 2013 Mar; 16(3):549-58. PubMed ID: 22691872
[TBL] [Abstract][Full Text] [Related]
16. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
Kyosiimire-Lugemwa J; Anywaine Z; Abaasa A; Levin J; Gombe B; Musinguzi K; Kaleebu P; Grosskurth H; Munderi P; Pala P
J Infect Dis; 2020 Jul; 222(3):381-390. PubMed ID: 31714954
[TBL] [Abstract][Full Text] [Related]
17. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
[TBL] [Abstract][Full Text] [Related]
18. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
19. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
20. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
